Krystal Biotech (KRYS) Earnings Date, Estimates & Call Transcripts $138.66 +2.56 (+1.88%) Closing price 04:00 PM EasternExtended Trading$138.71 +0.05 (+0.04%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Krystal Biotech Earnings Summary Krystal Biotech announced Q2 2025 earnings on August 4, 2025, reporting an EPS of $1.29, which topped analysts' consensus estimates of $1.08 by $0.21. Quarterly revenue was reported to be $96.04 million, above the consensus estimate of $95.42 million. With a trailing EPS of $4.92 and a P/E Ratio of 28.18, Krystal Biotech's earnings are expected to grow 64.17% next year, from $6.14 to $10.08 per share. Latest Q2 Earnings DateAug. 4EstimatedConsensus EPS (Aug. 4) $1.08 Actual EPS (Aug. 4) $1.29 Beat By $0.21 Actual Revenue (Aug. 4) $96.04MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckSEC FilingSlide DeckFull Screen Slide DeckPowered by Get Krystal Biotech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Krystal Biotech and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataKRYS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KRYS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Krystal Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252$1.31$1.56$1.44Q2 20252$1.12$1.26$1.19Q3 20252$1.06$1.14$1.10Q4 20252$1.09$1.61$1.35 FY 2025 8 $4.58 $5.57 $5.08 Q1 20261$1.40$1.40$1.40Q2 20261$1.88$1.88$1.88Q3 20261$2.16$2.16$2.16Q4 20261$2.93$2.93$2.93 Krystal Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025$1.08$1.29+$0.21$1.29$95.42M$96.04M5/6/2025Q1 2025$1.38$1.20 -$0.18$1.20$98.66M$88.18M2/24/2025Q4 2024$1.29$1.52+$0.23$1.52$91.35M$91.10M11/4/2024Q3 2024$0.84$0.91+$0.07$0.91$82.94M$83.84M8/5/2024Q2 2024$0.50$0.53+$0.03$1.19$65.27M$70.28M5/6/2024Q1 2024$0.20$0.03 -$0.17$0.03$47.37M$45.25M2/26/2024Q4 2023-$0.52$0.30+$0.82$0.30$27.43M$42.14M11/6/2023Q3 2023-$1.10$2.79+$3.89-$4.13$6.29M$8.60M Krystal Biotech Earnings - Frequently Asked Questions When did Krystal Biotech announce their last quarterly earnings? Krystal Biotech (NASDAQ:KRYS) last announced its quarterly earning data on Monday, August 4, 2025. Learn more on KRYS's earnings history. Did Krystal Biotech beat their earnings estimates last quarter? In the previous quarter, Krystal Biotech (NASDAQ:KRYS) reported $1.29 earnings per share (EPS) to beat the analysts' consensus estimate of $1.08 by $0.21. Learn more on analysts' earnings estimate vs. KRYS's actual earnings. How can I listen to Krystal Biotech's earnings conference call? The conference call for Krystal Biotech's latest earnings report can be listened to online. Listen to Conference Call How can I read Krystal Biotech's conference call transcript? The conference call transcript for Krystal Biotech's latest earnings report can be read online. Read Transcript How can I view Krystal Biotech's earnings report? Krystal Biotech's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Krystal Biotech generate each year? Krystal Biotech (NASDAQ:KRYS) has a recorded annual revenue of $290.52 million. How much profit does Krystal Biotech generate each year? Krystal Biotech (NASDAQ:KRYS) has a recorded net income of $89.16 million. KRYS has generated $4.92 earnings per share over the last four quarters. What is Krystal Biotech's price-to-earnings ratio? Krystal Biotech (NASDAQ:KRYS) has a trailing price-to-earnings ratio of 27.99 and a forward price-to-earnings ratio of 22.43. What is Krystal Biotech's EPS forecast for next year? Krystal Biotech's earnings are expected to grow from $6.14 per share to $10.08 per share in the next year, which is a 64.17% increase. More Earnings Resources from MarketBeat Related Companies TEVA Earnings GMAB Earnings RDY Earnings QGEN Earnings MRNA Earnings ASND Earnings VTRS Earnings BBIO Earnings VRNA Earnings BPMC Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Dutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 Lifeline This page (NASDAQ:KRYS) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
